Evelo Biosciences, Inc.

FMR LLC EVLO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/11/2023

Shares

16,197,089

Value ($000)

2,927

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/11/2023	2,927	0.0%	16,197,089	3/31/2023
2022 Q4	2/13/2023	26,450	0.0%	16,428,351	12/31/2022
2022 Q3	11/10/2022	33,856	0.0%	16,199,055	9/30/2022
2022 Q2	8/12/2022	34,152	0.0%	16,185,709	6/30/2022
2022 Q1	5/13/2022	27,277	0.0%	8,046,489	3/31/2022
2021 Q4	2/14/2022	48,676	0.0%	8,018,992	12/31/2021
2021 Q3	2/14/2022	56,389	0.0%	8,009,743	9/30/2021
2021 Q2	8/13/2021	110,003	0.0%	8,006,076	6/30/2021
2021 Q1	5/14/2021	85,603	0.0%	8,000,242	3/31/2021
2020 Q4	2/8/2021	82,253	0.0%	6,803,365	12/31/2020
2020 Q3	11/13/2020	26,355	0.0%	5,000,985	9/30/2020
2020 Q2	8/24/2020	22,301	0.0%	4,551,219	6/30/2020
2020 Q1	5/14/2020	12,094	0.0%	3,220,853	3/31/2020
2019 Q4	2/7/2020	13,164	0.0%	3,242,419	12/31/2019